Panja, Sukanya
Truica, Mihai Ioan http://orcid.org/0000-0002-0866-1407
Yu, Christina Y. http://orcid.org/0000-0002-4165-6781
Saggurthi, Vamshi http://orcid.org/0009-0005-1883-5588
Craige, Michael W. http://orcid.org/0000-0002-5548-0668
Whitehead, Katie
Tuiche, Mayra V. http://orcid.org/0000-0001-6865-2492
Al-Saadi, Aymen
Vyas, Riddhi
Ganesan, Shridar
Gohel, Suril
Coffman, Frederick
Parrott, James S. http://orcid.org/0000-0003-3486-9567
Quan, Songhua
Jha, Shantenu
Kim, Isaac
Schaeffer, Edward http://orcid.org/0000-0003-0699-1899
Kothari, Vishal http://orcid.org/0000-0001-7453-1435
Abdulkadir, Sarki A. http://orcid.org/0000-0003-2963-2899
Mitrofanova, Antonina http://orcid.org/0000-0003-0671-6512
Article History
Received: 13 August 2022
Accepted: 22 December 2023
First Online: 8 January 2024
Competing interests
: S.A.A. is a coinventor on patents covering the methods and assays to identify and characterize MYC inhibitors and derivatives (US11420957B2, “Substituted heterocycles as c-MYC targeting agents”). A.M., S.P., S.A.A. E.M.S., and V.K. are coinventors on patent applications covering the methods and assays to identify Enzalutamide-responsive tumors (PCT Application No. PCT/US2023/065533, “MYC program as a marker of response to Enzalutamide in prostate cancer”). A.M. and S.P. are coinventors on patent applications covering the computational method TR-2-PATH (U.S. Patent Application No. 18/297,470, “Identifying treatment response signatures”). The remaining authors declare no competing interests.